GLP-1 medications come with real costs and side effects, and the risk-benefit math does not support their use as a primary cancer prevention strategy
Most health plans do not cover the drugs unless you have a prescription and meet specific criteria
Resected disease artery was immersed in RANlater (Qiagen, Venlo, Netherlands) and stored until use
Dokken BB, Hilwig WR, Teachey MK, Panchal RA, Hubner K, Allen D, et al
600 mg to 1,200 mg IV per session Redox connection / NAD+ supports glutathione recycling via NADPH-dependent glutathione reductase Monitoring / liver enzymes (ALT, AST) at baseline and at 3 months if using injectable glutathione Who should be cautious / people on chemotherapy or with G6PD deficiency Evidence quality / mostly preclinical and early Phase I/II human data as of 2025 What Are NMN, NR, and Glutathione, and Why Do People Stack Them
Most patients experience peak discomfort during dose escalation phases, particularly when jumping to a new weekly injection strength